Skip to main content
Back
ADDLF logo

AddLife AB (publ)

Data quality: 100%
Overbought
ADDLF
OTC Healthcare Medical - Instruments & Supplies
$42.00
$0.00 (0.00%)
Mkt Cap: 4.93B
Day Range
$7.94 $42.00
52-Week Range
$7.94 $42.00
Volume
3,000
50D / 200D Avg
$42.00 / $42.00
Prev Close
$42.00

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (625 peers)

Metric Stock Sector Median
P/E 8.8 14.0
P/B 0.9 2.4
ROE % 10.4 11.4
Net Margin % 5.4 10.1
Rev Growth 5Y % 6.9 7.0
D/E 0.0 0.5

Key Takeaways

Revenue grew 6.91% annually over 5 years — modest growth
Earnings grew 122.22% over the past year
ROE of 10.42% — decent returns on equity
Debt/Equity of 0.00 — conservative balance sheet
Generating 1.39B in free cash flow
P/E of 8.80 — trading at a low valuation

Growth

Revenue Growth (5Y)
6.91%
Revenue (1Y)1.52%
Earnings (1Y)122.22%
FCF Growth (3Y)73.02%

Quality

Return on Equity
10.42%
ROIC13.68%
Net Margin5.36%
Op. Margin9.51%

Safety

Debt / Equity
0.00
Current Ratio1.04
Interest Coverage0.00

Valuation

P/E Ratio
8.80
P/B Ratio0.91
EV/EBITDA4.14
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 1.52% Revenue Growth (3Y) 3.83%
Earnings Growth (1Y) 122.22% Earnings Growth (3Y) 71.68%
Revenue Growth (5Y) 6.91% Earnings Growth (5Y) -6.06%
Profitability
Revenue (TTM) 10.44B Net Income (TTM) 560.00M
ROE 10.42% ROA 4.41%
Gross Margin 38.09% Operating Margin 9.51%
Net Margin 5.36% Free Cash Flow (TTM) 1.39B
ROIC 13.68% FCF Growth (3Y) 73.02%
Safety
Debt / Equity 0.00 Current Ratio 1.04
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio 8.80 P/B Ratio 0.91
P/S Ratio 0.47 PEG Ratio 0.69
EV/EBITDA 4.14 Dividend Yield 0.00%
Market Cap 4.93B Enterprise Value 4.11B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 10.44B 10.29B 9.69B 9.08B 7.99B
Net Income 560.00M 252.00M 190.00M 480.00M 719.00M
EPS (Diluted) 4.59 2.07 1.56 3.95 6.01
Gross Profit 3.98B 3.86B 3.60B 3.43B 2.86B
Operating Income 993.00M 721.00M 585.00M 808.00M 996.30M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 12.71B 13.06B 12.75B 13.06B 10.60B
Total Liabilities 7.26B 7.75B 7.79B 8.09B 6.30B
Shareholders' Equity 5.44B 5.31B 4.96B 4.97B 4.29B
Total Debt 0.0 5.07B 5.29B 5.59B 4.10B
Cash & Equivalents 813.00M 331.00M 272.00M 376.00M 345.30M
Current Assets 4.15B 3.93B 3.61B 3.57B 2.75B
Current Liabilities 3.99B 3.19B 4.31B 4.46B 4.91B

Strategy Scores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#748 of 814
15
Value Defensive Investing (Benjamin Graham)
#533 of 702
14

Recent Activity

Entered Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entered Defensive Investing (Benjamin Graham)
Mar 24, 2026